Inbeeo’s Post

🎯𝗜-𝗟𝗔𝗦 𝗥𝗲𝗰𝗮𝗽 #𝟯: 𝗜𝗻𝘁𝗲𝗴𝗿𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗔𝗰𝗰𝗲𝘀𝘀 𝗶𝗻𝘁𝗼 𝗗𝗲𝗰𝗶𝘀𝗶𝗼𝗻-𝗠𝗮𝗸𝗶𝗻𝗴 🎯 At the Inbeeo Leaders in Access Summit 2024, we discussed the importance of integrating access into decision-making. It is widely accepted that Market Access has yet to realise its full potential impact across all clinical development stages, particularly in preclinical and phase 1 development. What are the biggest impediments to developing a truly successful market access strategy?   -   Continued perception of Market Access as a specialist function as opposed to a strategic partner  -   Market access is often not represented in key decision forums due to the lack of organisational influence networks   -   Lack of truly effective influence networks and challenge of the Market Access representative to be a ‘listened to’ voice in the room So, how do we think these challenges could be overcome? -   𝗜𝗻𝗰𝗿𝗲𝗮𝘀𝗲𝗱 𝗳𝗼𝗰𝘂𝘀 𝗼𝗻 𝗮𝗰𝗰𝗲𝘀𝘀 𝗲𝗱𝘂𝗰𝗮𝘁𝗶𝗼𝗻, for example by requiring Market Access training for progression into corporate leadership roles, which would increase the awareness of access as a strategic function -   𝗦𝗲𝗲𝗸𝗶𝗻𝗴 𝗼𝘂𝘁 𝗮𝗰𝗰𝗲𝘀𝘀 𝗰𝗵𝗮𝗺𝗽𝗶𝗼𝗻𝘀 𝗶𝗻 𝗖-𝘀𝘂𝗶𝘁𝗲, peripheral leadership and governance, hiring more corporate leaders with a background in Market Access would help develop a broader appreciation of the importance of true strategic planning and effective execution  -   𝗠𝗮𝗸𝗶𝗻𝗴 𝘁𝗵𝗲 𝗰𝗮𝘀𝗲 𝗳𝗼𝗿 𝗴𝗿𝗲𝗮𝘁𝗲𝗿 𝗶𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁 𝗶𝗻 𝗮𝗰𝗰𝗲𝘀𝘀 by implementing early integrated value propositions, and providing clear impact scenarios Stay tuned for the final post from the Leaders in Access Summit on Corporate Social Responsibility in Access Strategy! Reach out to Enzo Straccia or Charlotte Langbo to learn more about our Inbeeo Leaders in Access events for 2025! #Pharmaceuticals #MarketAccess #ILAS #LeadersInAcccessSummit #AccessStrategy

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics